CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-20 | BAFFI ROBERT Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,050 | 12,050 | ||
| 2025-06-12 | BAFFI ROBERT Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,050 | 12,050 | ||
| 2024-06-14 | BAFFI ROBERT Director | Grant or award · Stock Option (Right to Buy) | +7,700 | 7,700 | ||
| 2024-01-16 | BAFFI ROBERT Director | Grant or award · Stock Option (Right to Buy) | +15,400 | 15,400 |
Page 1 of 1 · 4 trades